PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(8), P. e0308360 - e0308360
Published: Aug. 6, 2024
Increasing
evidence
has
shown
that
gut
microbiota
(GM)
was
involved
in
the
pathophysiology
of
musculoskeletal
disorders
through
multiple
pathways
such
as
protein
anabolism,
chronic
inflammation
and
immunity,
imbalanced
metabolism.
We
performed
a
systematic
review
meta-analysis
human
studies
to
evaluate
GM
diversity
differences
between
individuals
with
without
sarcopenia,
explore
bacteria
potential
become
biomarkers.
PubMed,
Embase
Cochrane
library
were
systematically
searched
from
inception
February
16,
2024.
Studies
included
if
they
(1)
sampled
adults
(2)
analysis
reported
α-diversity,
β-diversity
or
relative
abundance.
The
methodological
quality
certainty
assessed
Joanna
Briggs
Institute
critical
appraisal
checklist
for
analytical
cross-sectional
Grades
Recommendation,
Assessment,
Development
Evaluation
(GRADE)
Working
Group
system,
respectively.
Weighted
standardized
mean
(SMDs)
corresponding
95%
confidence
intervals
(CIs)
estimated
α-diversity
indices
using
fixed-effects
random-effects
model.
Beta
abundance
summarized
qualitatively.
A
total
19
involving
6,565
participants
this
study.
Compared
controls,
significantly
moderate
decrease
microbial
richness
sarcopenia
found
(Chao1:
SMD
=
-0.44;
95%CI,
-0.64
-0.23,
I
2
57.23%,
13
studies;
observed
species:
-0.68;
-1.00
-0.37,
66.07%,
5
ACE
index:
-0.30;
-0.56
-0.04,
8.12%,
4
studies),
very
low
evidence.
Differences
β
-diversity
consistently
84.6%
97.3%
participants.
detailed
differential
identified
loss
Prevotellaceae
,
Prevotella
Megamonas
compared
non-sarcopenia.
In
conclusion,
be
associated
reduced
GM,
supplementing
intestinal
described
above
may
contribute
preventing
treating
muscle
disease.
research
protocol
registered
approved
PROSPERO
(CRD42023412849).
Cardiovascular Research,
Journal Year:
2024,
Volume and Issue:
120(10), P. 1126 - 1137
Published: April 29, 2024
Cardiac
energy
metabolism
is
perturbed
in
ischaemic
heart
failure
and
characterized
by
a
shift
from
mitochondrial
oxidative
to
glycolysis.
Notably,
the
failing
relies
more
on
ketones
for
than
healthy
heart,
an
adaptive
mechanism
that
improves
energy-starved
status
of
heart.
However,
whether
this
can
be
implemented
therapeutically
remains
unknown.
Therefore,
our
aim
was
determine
if
increasing
ketone
delivery
via
ketogenic
diet
improve
outcomes
failure.
Reviews in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
25(7)
Published: July 2, 2024
Heart
failure
(HF)
is
a
clinical
syndrome
characterizing
by
typical
physical
signs
and
symptomatology
resulting
from
reduced
cardiac
output
and/or
intracardiac
pressure
at
rest
or
under
stress
due
to
structural
functional
abnormalities
of
the
heart.
HF
often
final
stage
all
cardiovascular
diseases
significant
risk
factor
for
sudden
arrest,
death,
liver
kidney
failure.
Current
pharmacological
treatments
can
only
slow
progression
recurrence
HF.
With
advancing
research
into
gut
microbiome
its
metabolites,
one
such
trimethylamine
N-oxide
(TMAO)—has
been
implicated
in
advancement
correlated
with
poor
prognosis
patients
However,
precise
role
TMAO
has
not
yet
clarified.
This
review
highlights
concludes
available
evidence
potential
mechanisms
associated
HF,
hope
contributing
new
insights
diagnosis
prevention
Clinical Epigenetics,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Nov. 29, 2024
The
gut
microbiota
(GM)
plays
a
critical
role
in
regulating
human
physiology,
with
dysbiosis
linked
to
various
diseases,
including
heart
failure
(HF).
HF
is
complex
syndrome
significant
global
health
impact,
as
its
incidence
doubles
each
decade
of
life,
and
prevalence
peaks
individuals
over
80
years.
A
bidirectional
interaction
exists
between
GM
HF,
where
alterations
can
worsen
the
disease's
progression.
"gut
hypothesis
HF"
suggests
that
HF-induced
changes,
such
reduced
intestinal
perfusion
altered
motility,
negatively
impact
composition,
leading
increased
permeability,
release
GM-derived
metabolites
into
bloodstream,
systemic
inflammation.
This
process
creates
vicious
cycle
further
deteriorates
function.
metabolites,
trimethylamine
N-oxide
(TMAO),
short-chain
fatty
acids
(SCFAs),
secondary
bile
(BAs),
influence
gene
expression
through
epigenetic
mechanisms,
DNA
methylation
histone
modifications.
These
changes
may
play
crucial
mediating
effects
dysbiotic
microbial
linking
them
cardiac
contributing
progression
HF.
particularly
relevant
older
individuals,
aging
itself
has
been
associated
both
cumulative
alterations,
intensifying
interplay
GM,
increasing
risk
elderly.
Despite
growing
body
evidence,
modifications,
remains
poorly
understood.
dynamic
nature
epigenetics
shaped
by
factors
age,
diet,
lifestyle,
presents
challenges
elucidating
precise
mechanisms
underlying
this
relationship.
Future
research
should
prioritize
innovative
approaches
overcome
these
limitations.
By
identifying
specific
metabolite-induced
modifications
modulating
composition
function
novel
personalized
therapeutic
strategies
for
prevention
and/or
treatment
be
developed.
Moreover,
targeted
focusing
specifically
on
understanding
intricate
connections
epigenetics,
during
aging.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(7), P. 2567 - 2567
Published: March 29, 2023
Despite
considerable
advances
in
the
field,
heart
failure
(HF)
still
poses
a
significant
disease
burden
among
affected
individuals
since
it
continues
to
cause
high
morbidity
and
mortality
rates.
Inflammation
is
considered
play
key
role
progression,
but
exact
underlying
pathophysiological
mechanisms
involved
have
not
yet
been
fully
elucidated.
The
gut,
as
potential
source
of
inflammation,
could
feasibly
explain
state
low-grade
inflammation
seen
patients
with
chronic
HF.
Several
derangements
composition
microbiota
population,
coupled
an
imbalance
between
favorable
harmful
metabolites
followed
by
gut
barrier
disruption
eventually
bacterial
translocation,
contribute
cardiac
dysfunction
aggravate
On
other
hand,
HF-associated
congestion
hypoperfusion
alters
intestinal
function,
thereby
creating
vicious
cycle.
Based
on
this
evidence,
novel
pharmaceutical
agents
developed
their
therapeutic
use
has
tested
both
animal
human
subjects.
ultimate
goal
these
efforts
reverse
aforementioned
block
cascade.
This
review
summarizes
gut-related
causative
pathways
implicated
HF
pathophysiology,
well
associated
interventions
described
literature.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(8), P. 2313 - 2313
Published: Aug. 21, 2023
Heart
failure
is
a
risk
factor
for
adverse
events
such
as
sudden
cardiac
arrest,
liver
and
kidney
death.
The
gut
microbiota
its
metabolites
are
directly
linked
to
the
pathogenesis
of
heart
failure.
As
emerging
studies
have
increased
in
literature
on
role
specific
development,
this
review
highlights
summarizes
current
evidence
underlying
mechanisms
associated
with
We
found
that
microbiota-derived
short
chain
fatty
acids,
bile
branched-chain
amino
tryptophan
indole
derivatives
well
trimethylamine-derived
metabolite,
trimethylamine
N-oxide,
play
critical
roles
promoting
through
various
mechanisms.
Mainly,
they
modulate
complex
signaling
pathways
nuclear
kappa-light-chain-enhancer
activated
B
cells,
Bcl-2
interacting
protein
3,
NLR
Family
Pyrin
Domain
Containing
inflammasome,
Protein
kinase
RNA-like
endoplasmic
reticulum
kinase.
also
highlighted
beneficial
other
cardiovascular
metabolic
diseases.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(21), P. 4544 - 4544
Published: Oct. 26, 2023
Various
studies
have
highlighted
the
important
associations
between
obstructive
sleep
apnea
(OSA)
and
gut
microbiota
related
metabolites.
Nevertheless,
establishment
of
causal
relationships
these
remains
to
be
determined.
Multiple
mendelian
randomization
(MR)
analyses
were
performed
genetically
predict
causative
impact
196
83
metabolites
on
OSA.
Two-sample
MR
was
used
assess
potential
association,
causality
evaluated
using
inverse
variance
weighted
(IVW),
MR-Egger,
median
(WM)
methods.
Multivariable
(MVMR)
employed
ascertain
independence
linked
Additionally,
Cochran’s
Q
test,
Egger
intercept
test
Steiger
for
sensitivity
analyses.
The
analysis
revealed
that
genus_Ruminococcaceae
(UCG009)
(PIVW
=
0.010)
genus_Subdoligranulum
0.041)
associated
with
an
increased
risk
OSA
onset.
Conversely,
Family_Ruminococcaceae
0.030),
genus_Coprococcus2
(PWM
0.025),
genus_Eggerthella
0.011),
genus_Eubacterium
(xylanophilum_group)
0.001)
negatively
Among
evaluated,
3-dehydrocarnitine,
epiandrosterone
sulfate,
leucine
determined
independent
factors
Moreover,
reverse
demonstrated
a
suggestive
association
exposure
six
taxa.
This
study
offers
compelling
evidence
regarding
beneficial
or
detrimental
its
risk,
thereby
providing
new
insights
into
mechanisms
microbiome-mediated
development.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2022,
Volume and Issue:
12
Published: May 17, 2022
Background
Recent
data
indicate
the
importance
of
gut-kidney
axis
in
pathogenesis
Immunoglobulin
A
nephropathy
(IgAN).
Growing
evidence
suggests
alterations
diversity
and
composition
gut
microbiome
among
patients
with
IgAN,
however,
details
are
not
yet
fully
understood.
Methods
Eligible
studies
comparing
between
IgAN
non-IgAN
individuals
were
systematically
searched
from
PubMed,
Embase,
Web
Science,
Cochrane
Library,
China
National
Knowledge
Infrastructure,
ClinicalTrials.gov
.
The
primary
outcomes
alpha-
beta-diversity,
differences
microbiota
persons.
Qualitative
analysis
meta-analysis
performed
according
to
available
data.
Results
Eleven
cross-sectional
studies,
including
409
243
healthy
controls,
enrolled.
No
significant
enrichment
bacteria
found
individuals,
whereas
beta-diversity
consistently
showed
microbial
dissimilarities
two
groups.
Firmicutes,
Bacteroidetes,
Actinobacteria,
Proteobacteria,
Fusobacteria
,
Verrucomicrobia
dominant
phyla,
no
controls
at
phylum
level.
genera,
Streptococcus
Paraprevotella
a
higher
proportion
compared
Fusicatenibacter
lower
abundance
meta-analysis.
analyses
suggested
that
Escherichia-Shigella
might
be
increased
patients;
Clostridium,
Prevotella
9
,and
Roseburia
members
Ruminococcaceae
Lachnospiraceae
families,
likely
have
decreased
abundances
individuals.
Conclusion
Gut
dysbiosis
was
demonstrated
which
involved
IgAN.
Further
needed
confirm
findings
this
study,
due
substantial
heterogeneity.
Systematic
Review
Registration
https://www.crd.york.ac.uk/prospero/
identifier
PROSPERO
(CRD42022304034).
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(4), P. 809 - 809
Published: March 30, 2022
Growing
evidence
suggests
an
altered
gut
microbiome
in
patients
with
heart
failure
(HF).
However,
the
exact
interrelationship
between
microbiota,
HF,
and
its
consequences
on
metabolome
are
still
unknown.
We
thus
aimed
here
to
decipher
association
severity
progression
of
HF
composition
circulating
metabolites.
Using
a
mouse
model
transverse
aortic
constriction
(TAC),
bacterial
diversity
was
found
be
significantly
lower
mice
as
early
day
7
post-TAC
compared
Sham
controls
(p
=
0.03),
gradual
progressive
decrease
alpha-diversity
days
7,
14,
42
0.014,
p
0.0016,
0.0021)
0,
which
coincided
compensated
hypertrophy,
maladaptive
overtly
failing
hearts,
respectively.
Strikingly,
segregated
analysis
based
cardiac
dysfunction
(EF
<
40%
vs.
EF
40−55%)
manifested
marked
differences
abundance
grouping
several
taxa.
Multivariate
plasma
metabolites
produced
strong
correlation
metabolic
alterations,
such
reduced
short-chain
fatty
acids
increase
primary
bile
acids,
differential
distinct
bacteria
HF.
In
conclusion,
we
showed
that
begets
likely
via
vicious
cycle
products.